The impact of interferon (IFN)‐free therapies on the epidemiology of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) is not well understood at a population level. Our goal was to… Click to show full abstract
The impact of interferon (IFN)‐free therapies on the epidemiology of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) is not well understood at a population level. Our goal was to bridge this evidence gap.
               
Click one of the above tabs to view related content.